Atea Pharmaceuticals Capital Expenditures (CapEx) Growth & History (AVIR)
Atea Pharmaceuticals's capital expenditures (capex) was $1.9M for fiscal 2022.
View full Atea Pharmaceuticals company overviewAtea Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $1.9M | $1.9M | +48475.00% |
| 2021 | 2021-12-31 | $4,000 | −$22,000 | −84.62% |
| 2020 | 2020-12-31 | $26,000 | $24,000 | +1200.00% |
| 2019 | 2019-12-31 | $2,000 | −$10,000 | −83.33% |
| 2018 | 2018-12-31 | $12,000 | — | — |
Atea Pharmaceuticals quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2022 | 2022-12-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $20,000 | — | — |
| Q2 2022 | 2022-06-30 | $1.9M | — | — |
| Q1 2022 | 2022-03-31 | $44,000 | — | — |
| Q3 2020 | 2020-09-30 | $15,000 | — | — |
Atea Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2018-12-31 and 2022-12-31, Atea Pharmaceuticals's capital expenditures (capex) increased from $12,000 to $1.9M, a change of $1.9M. The latest reported quarter, Q4 2022, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atea Pharmaceuticals source filings ↗